We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Age of Red Blood Cells in Premature Infants Study (ARIPI)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00326924
First Posted: May 17, 2006
Last Update Posted: October 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Ottawa Hospital Research Institute
May 15, 2006
May 17, 2006
October 12, 2017
May 2006
June 2012   (Final data collection date for primary outcome measure)
1. composite outcome of necrotizing enterocolitis, intraventricular hemorrhage, bronchopulmonary dysplasia and retinopathy of prematurity at 30 and 90-days. 2. mortality [ Time Frame: 2 weeks, 4 weeks, 12 weeks, 90 days ]
1. composite outcome of necrotizing enterocolitis, intraventricular hemorrhage, bronchopulmonary dysplasia and retinopathy of prematurity at 30 and 90-days. 2. mortality
Complete list of historical versions of study NCT00326924 on ClinicalTrials.gov Archive Site
1. individual rates of NEC, IVH, BPD and ROP at 30 and 90 days. 2. incidence of nosocomial infection 3. length of stay in NICU 4. length of mechanical ventilation [ Time Frame: 2 weeks, 4 weeks, 12 weeks, 90 days ]
1. individual rates of necrotizing enterocolitis, intraventricular hemorrhage, bronchopulmonary dysplasia and retinopathy of prematurity at 30 and 90 days. 2. incidence of nosocomial infection 3. length of stay in NICU 4. length of mechanical ventilation
Not Provided
Not Provided
 
Age of Red Blood Cells in Premature Infants Study (ARIPI)
Age of Red Blood Cells in Premature Infants Study (ARIPI)
To determine if the age of blood transfused to new borns in the NICU setting has an impact on their outcome.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Premature Birth
Biological: Transfusion
PRBC blood transfusions.
Other Name: non applicable
  • Experimental: Biological
    PRBCs that are less than 7 days old are considered 'fresh'.
    Intervention: Biological: Transfusion
  • Experimental: Standard PRBCs
    PRBCs 'stored' as per hospital policy.
    Intervention: Biological: Transfusion

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
377
June 2012
June 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • birthweight of less than 1250g
  • admitted to participating NICU
  • consent acquired from proxy for the patient

Exclusion Criteria:

  • already received one or more transfusions
  • requirement for an exchange transfusion
  • will be receiving directed donations
  • have rare blood types/difficult cross-match
  • proxy has refused consent
  • moribund on admission to NICU/expected to die
  • mitigating child protection issues
Sexes Eligible for Study: All
up to 37 Weeks   (Child)
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
 
NCT00326924
2004706-01H
Yes
Not Provided
Not Provided
Ottawa Hospital Research Institute
Ottawa Hospital Research Institute
Not Provided
Study Director: Dean Fergusson, PhD OHRI
Ottawa Hospital Research Institute
November 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP